TY - JOUR JO - EuroIntervention TI - DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial AB - <p class="text-1er-paragraph"><span class="abstracts-titres">Aims:</span> Newer-generation drug-eluting stents (DES) have been shown to be superior to first-generation DES. Current-generation DES have zotarolimus, everolimus or biolimus as antiproliferati AU - Iqbal Javaid AU - Verheye Stefan AU - Abizaid A. Alexandre AU - Ormiston A. John AU - De Vries Ton AU - Morrison Lynn AU - Toyloy Sara AU - Fitzgerald Peter J. AU - Windecker Stephan AU - Serruys Patrick W. VL - 12 IS - 11 Y1 - 09/12/2016 Y1 - 2016 DOI - 10.4244/EIJY15M10_04 SP - e1336 EP - e1342 KW - drug-eluting stents KW - novolimus KW - zotarolimus PB - Europa Digital & Publishing SE - CORONARY INTERVENTIONS UR - https://eurointervention.pcronline.com/article/desyne-novolimus-eluting-coronary-stent-is-superior-to-endeavor-zotarolimus-eluting-coronary-stent-at-five-year-follow-up-final-results-of-the-multicentre-excella-ii-randomised-controlled-trial SN - 1774-024X ER -